迅來智慧生醫製造股份有限公司
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Streamline Bio Taiwan Corporation primarily provides AI-driven cell and gene therapy manufacturing automation platforms. Its core products include autonomous precision robotic systems, process control software, and integrated biomanufacturing workflow solutions. The platform automates operations such as cell culture, liquid handling, sample analysis, quality control testing, and process data acquisition. By leveraging closed-loop control and intelligent scheduling technologies, it enhances production efficiency and batch-to-batch consistency. The system seamlessly integrates with existing biomanufacturing equipment and GMP production environments. It is applicable to manufacturing workflows for CAR-T, cell therapy, gene therapy, and advanced therapy medicinal products (ATMPs), helping biotechnology companies reduce production costs, shorten technology transfer timelines, and accelerate the commercialization process.
The content above was translated by Ai
Founded Year
2024
Unified Business No.
00245297
Status
Active
Number of Employees
0
Total Paid-in
Capital
2,400,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Streamline Bio Taiwan Corporation focuses on the development of process automation technology for cell and gene therapy (CGT), integrating artificial intelligence, robotics, and bioprocess engineering to build a smart manufacturing platform suitable for the cell therapy industry. With AI-driven Precision Robotics at its core, the company provides modular automation systems that can be directly integrated into existing cleanrooms and production environments, assisting biotechnology and pharmaceutical companies in reducing reliance on manual operations and improving process consistency and production quality. Its technical architecture features device-agnostic, process-agnostic, and modular expansion characteristics, which can meet the demands of different stages from research and development (R&D) and pilot-scale to commercial mass production, driving the cell and gene therapy industry toward smart and large-scale production.
The content above was translated by Ai
